Z92.22
Personal history of monoclonal drug therapy
Clinical Classification Guidelines
Excludes Type 2
- personal history of immune checkpoint inhibitor therapy (Z92.26)
Medical Intelligence & Overview
ICD-10 Code Z92.22 refers to a patient's personal medical history of undergoing monoclonal drug therapy. This classification helps healthcare providers document and communicate a patient's past treatment experiences, which can be important for ongoing medical care, future treatments, and understanding potential risks or reactions. Monoclonal therapy involves the use of laboratory-produced molecules that mimic the immune system's ability to fight specific targets, such as cancer cells or autoimmune components. Recording this history ensures continuity of care and informs clinical decisions relevant to the patient's medical background.
Causes & Symptoms
Clinical Causes: Treatment of certain types of cancer, such as lymphoma or multiple myeloma, using monoclonal antibodies. Management of autoimmune diseases like rheumatoid arthritis or Crohn's disease with monoclonal antibody therapy. Use in organ transplant recipients to prevent rejection through monoclonal antibody medications. Preventive or therapeutic use for infectious diseases, depending on the clinical scenario.
Key Symptoms: There are typically no direct symptoms associated with a history of monoclonal drug therapy itself. Patients may have symptoms related to the underlying condition treated, such as cancer-related fatigue or autoimmune symptoms. Possible side effects from monoclonal therapies experienced during or after treatment, like infusion reactions or allergic responses, which are recorded in medical history. Monitoring during future treatments might include noting previous adverse reactions or immune responses associated with such therapies.
Diagnostic & Treatment
Diagnosis Path: A personal history of monoclonal drug therapy is documented based on medical records that detail prior treatments. Healthcare providers verify past infusions, prescriptions, and reactions to establish this history. It is not diagnosed as a condition but recorded for clinical documentation and treatment planning purposes, usually by reviewing patient medical records or treatment histories.
Treatment Protocols: This ICD-10 code does not denote an active treatment but indicates a past medical intervention. Future treatments involving monoclonal therapy may be influenced by this history, and healthcare providers will consider previous responses and side effects to optimize ongoing or future therapies.
Clinical Advice & FAQs
Billing Guidance
Is Z92.22 a billable ICD-10 code?
Yes, Z92.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z92.22?
Clinical documentation must specify the nature of Personal history of monoclonal drug therapy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference